| 2023-09-20 | Facial nerve palsy - UMN VS LMN | 0:43 | 4 | |
|
| 2023-09-20 | CNS lesions and effects | 0:32 | 1 | |
|
| 2023-09-20 | Differential diagnosis of dementia | 1:36 | 2 | |
|
| 2023-09-20 | Medullary and Weber syndrome | 0:32 | 1 | |
|
| 2023-09-20 | Abnormal movements | 1:43 | 4 | |
|
| 2023-09-20 | Types of intracranial hemorrhage | 0:32 | 0 | |
|
| 2023-09-20 | Medical treatment of Parkinsons disease | 1:22 | 0 | |
|
| 2023-09-20 | GULLIAN Barr syndrome types | 0:32 | 4 | |
|
| 2023-09-20 | Drugs causing secondary Parkinsonism | 0:36 | 2 | |
|
| 2023-09-20 | Spinal segments and corresponding vertebral bodies | 0:32 | 2 | |
|
| 2023-09-20 | Parkinson’s disease features | 0:52 | 2 | |
|
| 2023-09-20 | Conus medullaris syndrome vs cauda equina syndrome | 0:32 | 3 | |
|
| 2023-09-20 | Causes of headache | 0:33 | 1 | |
|
| 2023-09-20 | Myasthenia gravis treatment | 0:32 | 6 | |
|
| 2023-09-20 | PELIZAEUS merzbacher disease | 1:02 | 7 | |
|
| 2023-09-20 | PELIZAEUS merzbacher disease | 0:32 | 2 | |
|
| 2023-09-19 | Myasthenia gravis treatment | 1:01 | 0 | |
|
| 2023-09-19 | Causes of headache | 0:32 | 2 | |
|
| 2023-09-19 | Conus medullaris syndrome vs cauda equina syndrome | 1:16 | 1 | |
|
| 2023-09-19 | Parkinson’s disease features | 0:32 | 1 | |
|
| 2023-09-19 | Spinal segments and corresponding vertebral bodies | 0:27 | 0 | |
|
| 2023-09-19 | Drugs causing secondary Parkinsonism | 0:32 | 2 | |
|
| 2023-09-19 | GULLIAN Barr syndrome types | 0:55 | 0 | |
|
| 2023-09-19 | Medical treatment of Parkinsons disease | 0:32 | 2 | |
|
| 2023-09-19 | Types of intracranial hemorrhage | 2:59 | 0 | |
|
| 2023-09-19 | Abnormal movements | 0:32 | 4 | |
|
| 2023-09-19 | Medullary and Weber syndrome | 1:20 | 3 | |
|
| 2023-09-19 | Differential diagnosis of dementia | 0:32 | 6 | |
|
| 2023-09-19 | CNS lesions and effects | 1:12 | 5 | |
|
| 2023-09-19 | Facial nerve palsy - UMN VS LMN | 0:32 | 2 | |
|
| 2023-09-19 | Structures damaged And effects | 0:48 | 5 | |
|
| 2023-09-18 | Pulmonary embolism wells criteria | 0:37 | 4 | |
|
| 2023-09-18 | Insulin classification - duration of action | 0:48 | 5 | |
|
| 2023-09-18 | Golds criteria COPD | 0:37 | 5 | |
|
| 2023-09-18 | Hypercalcemia clinical features | 1:01 | 4 | |
|
| 2023-09-18 | Hypercalcemia clinical features | 0:37 | 4 | |
|
| 2023-09-18 | Curb 65 criteria | 0:25 | 2 | |
|
| 2023-09-18 | Insulin classification - duration of action | 0:37 | 4 | |
|
| 2023-09-18 | Pulmonary embolism wells criteria | 0:42 | 1 | |
|
| 2023-09-18 | Type 1 vs type 2 Diabetes Mellitus | 0:37 | 2 | |
|
| 2023-09-18 | Golds criteria COPD | 0:47 | 2 | |
|
| 2023-09-18 | Hyponadotrophic Hypogonadism causes | 0:37 | 4 | |
|
| 2023-09-18 | Rheumatoid arthritis - most common | 1:01 | 4 | |
|
| 2023-09-18 | Rheumatoid arthritis - most common | 0:37 | 5 | |
|
| 2023-09-18 | Hyponadotrophic Hypogonadism causes | 0:35 | 3 | |
|
| 2023-09-18 | Curb 65 criteria | 0:37 | 3 | |
|
| 2023-09-18 | Type 1 vs type 2 Diabetes Mellitus | 1:41 | 4 | |
|
| 2023-09-17 | Cushing syndrome - causes | 0:37 | 3 | |
|
| 2023-09-17 | MEN 2 syndrome features | 0:37 | 3 | |
|
| 2023-09-17 | MEN 1 syndrome features | 0:37 | 1 | |
|
| 2023-09-17 | Addison disease - clinical features | 1:11 | 1 | |
|
| 2023-09-16 | Cushing syndrome - diagnostic tests | 0:33 | 1 | |
|
| 2023-09-16 | Cushing syndrome - clinical features | 1:21 | 0 | |
|
| 2023-09-16 | Cushing syndrome - causes | 1:19 | 0 | |
|
| 2023-09-16 | Hypothyroidism causes | 0:37 | 1 | |
|
| 2023-09-16 | Hypothyroidism evaluation | 0:37 | 1 | |
|
| 2023-09-16 | Thyrotoxicosis evaluation | 0:37 | 1 | |
|
| 2023-09-16 | Graves ophthalmopathy signs | 0:37 | 1 | |
|
| 2023-09-16 | Causes of SIADH | 0:37 | 1 | |
|
| 2023-09-16 | MEN 2 syndrome features | 1:05 | 0 | |
|
| 2023-09-16 | MEN 1 syndrome features | 0:56 | 1 | |
|
| 2023-09-16 | Hypothyroidism causes | 1:13 | 3 | |
|
| 2023-09-16 | Hypothyroidism evaluation | 1:57 | 1 | |
|
| 2023-09-16 | SIADH - Bartter Schwartz criteria | 0:37 | 4 | |
|
| 2023-09-15 | Thyrotoxicosis evaluation | 1:57 | 1 | |
|
| 2023-09-15 | Graves ophthalmopathy signs | 1:16 | 2 | |
|
| 2023-09-15 | Causes of SIADH | 1:57 | 0 | |
|
| 2023-09-15 | SIADH - Bartter Schwartz criteria | 0:32 | 2 | |
|
| 2023-09-15 | Diabetic Insipidus | 1:56 | 2 | |
|
| 2023-09-15 | Approach to polyuria | 0:53 | 1 | |
|
| 2023-09-15 | Osmolality and conditions | 0:58 | 3 | |
|
| 2023-09-14 | Diabetic Insipidus | 0:59 | 4 | |
|
| 2023-09-14 | Approach to polyuria | 0:59 | 0 | |
|
| 2023-09-14 | Osmolality and conditions | 0:59 | 0 | |
|
| 2023-09-08 | Hepatitis C infection transmission | 1:20 | 7 | |
|
| 2023-09-08 | Acute vs chronic hepatitis - histological features | 2:48 | 1 | Vlog |
|
| 2023-09-08 | NASH - Non alcoholic steatohepatitis | 1:17 | 1 | |
|
| 2023-09-08 | Types of metastasis - osteoblasts and osteocytes | 2:12 | 3 | |
|
| 2023-09-08 | Tumor markers in testicular germ cell tumors | 1:22 | 2 | |
|
| 2023-09-08 | Seminomatous germ cell tumors vs non seminomatous germ cell tumors | 3:29 | 1 | |
|
| 2023-09-08 | Hepatitis C infection transmission | 0:59 | 3 | |
|
| 2023-09-08 | Acute vs chronic hepatitis - histological features | 0:59 | 2 | Vlog |
|
| 2023-09-08 | NASH - Non alcoholic steatohepatitis | 0:59 | 3 | |
|
| 2023-09-08 | Types of metastasis - osteoblasts and osteocytes | 0:59 | 2 | |
|
| 2023-09-08 | Tumor markers in testicular germ cell tumors | 0:59 | 12 | |
|
| 2023-09-08 | Seminomatous germ cell tumors vs non seminomatous germ cell tumors | 0:59 | 3 | |
|
| 2023-08-28 | Microscopic appearance of various stones | 0:59 | 1 | |
|
| 2023-08-28 | Jackson staging of penile carcinoma | 0:47 | 0 | |
|
| 2023-08-28 | Syndromic association of wilms tumour | 0:59 | 1 | |
|
| 2023-08-28 | Lymph node levels in neck | 1:45 | 5 | |
|
| 2023-08-28 | Microscopic appearance of various stones | 3:15 | 0 | |
|
| 2023-08-28 | Jackson staging of penile carcinoma | 0:59 | 1 | |
|
| 2023-08-28 | Salivary gland - one liners | 2:16 | 0 | |
|
| 2023-08-28 | Salivary gland - one liners | 0:59 | 2 | |
|
| 2023-08-28 | Syndromic association of wilms tumour | 3:58 | 2 | |
|
| 2023-08-27 | Pleomorphic adenoma | 0:59 | 1 | |
|
| 2023-08-27 | Pleomorphic adenoma | 4:01 | 5 | |
|
| 2023-08-27 | Lymph node levels in neck | 0:59 | 2 | |
|
| 2023-08-22 | Hormonal contraceptives - part 2 | 4:05 | 3 | |
|
| 2023-08-22 | Hormonal contraceptives - part 2 | 0:59 | 0 | |
|
